Resultados CaixaImpulse 2024
Resultados CaixaImpulse 2024
CaixaImpulse 2024 information |
|
|---|---|
Total budget |
3.381.759 € |
Number of proposals submitted |
413 |
Number of eligible proposals |
406 |
Number of projects pre-selected |
72 |
Number of projects selected |
29 |
Success rate |
7 % |
Table 1. General information of the CaixaImpulse Health Innovation Call 2024
Figure 1. Number of projects selected by territory and project stage
PROJECT STAGE |
PROPOSALS SUBMITTED |
PROJECTS PRE-SELECTED |
PROJECTS SELECTED |
||
|---|---|---|---|---|---|
Stage 1 |
224 |
30 |
13,4 % |
16 |
7,1 % |
Stage 2 |
166 |
30 |
18 % |
11 |
6,6 % |
Stage 3 |
23 |
12 |
52,2 % |
2 |
8,7 % |
|
413 |
72 |
17 % |
29 |
7 % |
Table 2. Success rate by project stage
PROJECT STAGE |
THERAPEUTIC |
MEDICAL TECHNOLOGY |
TOTAL |
|---|---|---|---|
Stage 1 |
6 |
10 |
16 |
Stage 2 |
5 |
6 |
11 |
Stage 3 |
1 |
1 |
2 |
|
12 |
17 |
29 |
Table 3. Number of projects selected by business area and project stage
PROJECT LEADER |
PROPOSALS SUBMITTED |
PROJECTS PRE-SELECTED |
PROJECTS SELECTED |
|---|---|---|---|
Women |
188 |
33 |
7 |
Men |
219 |
38 |
21 |
Others |
1 |
0 |
0 |
Prefer not to say |
5 |
1 |
1 |
Table 4. Results by gender
Resultados CaixaImpulse 2023
Resultados CaixaImpulse 2023
CaixaImpulse 2023 information |
|
|---|---|
Total budget |
3.321.911 € |
Number of proposals submitted |
318 |
Number of eligible proposals |
315 |
Number of projects pre-selected |
70 |
Number of projects selected |
29 |
Success rate |
9,1 % |
Table 1. General information of the CaixaImpulse Health Innovation Call 2023
Figure 1. Number of proposals submitted by territory
Figure 2. Number of projects selected by territory
Project phase |
Proposals submitted |
Projects pre-selected |
Projects selected |
||
|---|---|---|---|---|---|
Phase 1 |
188 |
30 |
16 % |
15 |
8 % |
Phase 2 |
108 |
30 |
28 % |
12 |
11 % |
Phase 3 |
22 |
10 |
45 % |
2 |
9 % |
|
318 |
70 |
22 % |
29 |
9 % |
Table 2. Success rate by project phase
Project phase |
Therapeutic |
Medical technology |
Total |
|---|---|---|---|
Phase 1 |
6 |
9 |
15 |
Phase 2 |
6 |
6 |
12 |
Phase 3 |
1 |
1 |
2 |
|
13 |
16 |
29 |
Table 3. Number of projects selected by thematic area and project phase
Project leader |
Proposals submitted |
Projects preselected |
Projects selected |
||
|---|---|---|---|---|---|
Women |
156 |
38 |
24 % |
16 |
10 % |
Men |
162 |
32 |
20 % |
13 |
8 % |
|
318 |
70 |
22 % |
29 |
9 % |
Table 4. Results by gender
Projetos selecionados CaixaImpulse 2024
Projetos selecionados CaixaImpulse 2024
Code |
Title |
Project leader |
Centre |
Modality |
Partner institutions |
Stage |
Business area |
Budget (€) |
|---|---|---|---|---|---|---|---|---|
CI24-10034 |
Improving taxol response through the manipulation of the cancer tubulin code |
Sonia Silva |
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação |
Consortium |
Universidade do Porto |
STAGE 1 |
Therapeutics |
49,967,00 |
CI24-10180 |
Molecular glue degraders for a novel drug target in acute myeloid leukemia |
Marcus Buschbeck |
Fundació Institut de Recerca Contra la Leucèmia Josep Carreras |
Individual |
N/A |
STAGE 1 |
Therapeutics |
49,000,00 |
CI24-10227 |
Generating tissue resident memory T cells for cancer immunotherapy |
Marc Veldhoen |
Instituto de Medicina Molecular |
Individual |
N/A |
STAGE 1 |
Therapeutics |
50,000,00 |
CI24-10473 |
Chemical inhibition of novel Diffuse Midline Glioma vulnerabilities |
Luciano Di Croce |
Fundació Centre de Regulació Genòmica (CRG) |
Individual |
N/A |
STAGE 1 |
Therapeutics |
50,000,00 |
CI24-10612 |
Manuel Portero |
Institut De Recerca Biomedica De Lleida. Fundació Dr. Pifarre |
Individual |
N/A |
STAGE 1 |
Therapeutics |
41,000,00 |
|
CI24-10630 |
Non-opioid light-activated drugs for pain management without side effects |
Amadeu Llebaria |
Consejo Superior de Investigaciones Científicas (CSIC) |
Consortium |
Institut de Génomique Fonctionnelle (France); University of Montpellier (France) |
STAGE 1 |
Therapeutics |
50,000,00 |
CI24-10110 |
Genetic predisposition to myocardial infarction in the young |
Ramon Brugada |
Institut d'Investigació Biomèdica de Girona (IDIBGI) |
Individual |
N/A |
STAGE 1 |
Diagnostics |
49,000,00 |
CI24-10322 |
CELLECTED - An Innovative Approach for Non-Invasive Bladder Cancer Detection and Patient Monitoring |
Raphaël Canadas |
Universidade do Porto |
Individual |
N/A |
STAGE 1 |
Diagnostics |
49,999,00 |
CI24-10486 |
Pablo Naval |
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Individual |
N/A |
STAGE 1 |
Medical Devices |
50,000,00 |
|
CI24-10491 |
An aptamer-based rapid diagnostic test for the simultaneous detection of malaria and dengue |
Claudio Parolo |
Institut de Salut Global de Barcelona (ISGlobal) |
Consortium |
FURV-Fundació Universitat Rovira i Virgili |
STAGE 1 |
Diagnostics |
50,000,00 |
CI24-10670 |
Validation of a new methodology and biomarkers for predicting relapse in endometrial cancer patients |
Maria J. Macias |
Fundació Institut de Recerca Biomèdica (IRB Barcelona) |
Individual |
N/A |
STAGE 1 |
Diagnostics |
50,000,00 |
CI24-10681 |
Leveraging Genomics and AI for Non-Invasive Detection of Endometrial Cancer, a Urine Sample Solution |
Laura Costas |
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Individual |
N/A |
STAGE 1 |
Diagnostics |
50,000,00 |
CI24-10743 |
Artificial Intelligence system for predicting embolisms in infective endocarditis |
J. Alberto San Román |
Hospital Clínico Universitario de Valladolid |
Individual |
N/A |
STAGE 1 |
Diagnostics |
50,000,00 |
CI24-10063 |
Biomimetic Bacterial NanoCellulose medical device with gradient porosity for osteochondral repair |
Miguel Gama |
Universidade do Minho |
Consortium |
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação; Universidade de Trás-os-Montes e Alto Douro |
STAGE 1 |
Medical Devices |
50,000,00 |
CI24-10305 |
Focused ultrasound therapy for repairing spinal cord in people with Multiple Sclerosis (MS) |
Pablo Villoslada |
Fundació Institut Hospital del Mar d'Investigacions Mèdiques (IMIM) |
Individual |
N/A |
STAGE 1 |
Medical Devices |
50,000,00 |
CI24-10293 |
Hereditary Diffuse Gastric Cancer origins disclosed by organoid driven organ-on-chip technology |
Daniel A. Ferreira |
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação |
Individual |
N/A |
STAGE 1 |
Diagnostics |
49,000,00 |
CI24-20222 |
NanoERT: nano-delivery platform for Enzyme Replacement Therapy in Parkinson's and Gaucher's disease |
Julia Lorenzo |
Universitat Autònoma de Barcelona (UAB) |
Consortium |
Fundación de la Comunidad Valenciana Centro de Investigación Príncipe Felipe; Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR) |
STAGE 2 |
Therapeutics |
150,000,00 |
CI24-20449 |
Cecilia Rodrigues |
FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento |
Individual |
N/A |
STAGE 2 |
Therapeutics |
150,000,00 |
|
CI24-20467 |
Development of a microRNA-regulated cell death-inducing gene therapy (miRGT) for cancer |
Ana Rita Fragoso |
Instituto de Medicina Molecular |
Individual |
N/A |
STAGE 2 |
Therapeutics |
149,032,50 |
CI24-20581 |
Towards an effective and safe therapy for hormonal-deficiency osteoporosis based on klotho protein |
Joan Roig |
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR) |
Consortium |
Universitat Autònoma de Barcelona (UAB) |
STAGE 2 |
Therapeutics |
145,850,00 |
CI24-20693 |
Targeting CDK16-18 as a novel strategy against aggressive cancers |
Marcos Malumbres |
Fundació privada Institut Investigació Oncologica Vall d'Hebron (VHIO) |
Individual |
N/A |
STAGE 2 |
Therapeutics |
150,000,00 |
CI24-20107 |
A medical brain computer interface device to improve social cognition in autism spectrum disorder |
Miguel Castelo-Branco |
Universidade de Coimbra |
Individual |
N/A |
STAGE 2 |
Medical Devices |
148,980,19 |
CI24-20130 |
Artificial intelligence collaborative robot for patient-specific laser treatment of vascular lesions |
Bruno Oliveira |
Instituto Politécnico do Cávado e do Ave |
Consortium |
University of Southern Denmark (Dinamarca) |
STAGE 2 |
Medical Devices |
150,000,00 |
CI24-20329 |
Famba: international surveillance and data analytics platform for prevention of emerging pandemics |
José Muñoz |
Institut de Salut Global de Barcelona (ISGlobal) |
Consortium |
Institute of Tropical Medicine, Antwerp (Belgium); LMU Klinikum (Germany); IRCCS Ospedale Sacro-Cuore Don Calabria (Italy) |
STAGE 2 |
Digital Health |
149,930,00 |
CI24-20447 |
CRISPR-Cas Endonuclease Chain Reaction: a revolution in point-of-care genetic testing |
Felipe Cortés |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III |
Individual |
N/A |
STAGE 2 |
Diagnostics |
150,000,00 |
CI24-20499 |
NeurAntigen: A Human Neural Method for the Diagnosis of Autoimmune Encephalitis |
Eugenia Martínez Hernández |
Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer |
Consortium |
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
STAGE 2 |
Diagnostics |
150,000,00 |
CI24-20039 |
Salvio Suárez |
Fundació Institut Català de Nanociència i Nanotecnologia |
Individual |
N/A |
STAGE 2 |
Medical Devices |
150,000,00 |
|
CI24-30620 |
Heptammune: a first-in-class biologic immunomodulator against autoimmune inflammatory bowel disease |
Josep M. Aran |
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Individual |
N/A |
STAGE 3 |
Therapeutics |
500,000,00 |
CI24-30165 |
Víctor Rodriguez |
Consejo Superior de Investigaciones Científicas (CSIC) |
Individual |
N/A |
STAGE 3 |
Medical Devices |
499,000,00 |
Projetos selecionados CaixaImpulse 2023
Projetos selecionados CaixaImpulse 2023
Code |
Title |
Project leader |
Centre |
Modality |
Partner institutions |
Stage |
Business area |
Budget (€) |
|---|---|---|---|---|---|---|---|---|
CI23-10022 |
Smart dendritic contrast agent for accurate stroke diagnosis by computed tomography |
Victoria Leiro |
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação |
Individual |
N/A |
STAGE |
Diagnostics |
49,996(*) |
CI23-10074 |
Pre-clinical development of a DNA vaccine to elicit immunity against K. pneumoniae virulence factors |
Mireia López |
Universitat de Girona |
Individual |
N/A |
STAGE |
Therapeutics |
50,000 |
CI23-10079 |
Overcoming resistance to virotherapy for pediatric brain tumors |
Marta Alonso |
Fundación para la Investigación Médica Aplicada (FIMA/CIMA) |
Individual |
N/A |
STAGE |
Therapeutics |
50,000 |
CI23-10134 |
Nano-coatings for prosthetics based on microbial phenazines conjugated with silver nanostars |
Pedro Soares |
Instituto de Medicina Molecular |
Individual |
N/A |
STAGE |
Medical Devices |
50,000 |
CI23-10157 |
Revolutionizing Electronic Skin: Biobatteries Powered |
Ana Pina |
Universidade Nova de Lisboa |
Consortium |
Materials Research UCIBIO - Applied Molecular Biosciences Instituto de Tecnologia - Química e Instituto Gulbenkian de Ciência |
STAGE |
Medical Devices |
49,000 |
CI23-10184 |
Luisa Lopes |
Instituto de Medicina Molecular |
Individual |
N/A |
STAGE |
Therapeutics |
50,000 |
|
CI23-10272 |
A versatile and stress-resistant biocatalyst nanoplatform for pathogen detection |
Mónica Serrano |
Universidade Nova de Lisboa |
Individual |
N/A |
STAGE |
Diagnostics |
49,000 |
CI23-10330 |
A novel liquid biopsy approach for early breast cancer detection in lactating women |
Ana Vivancos |
Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO) |
Individual |
N/A |
STAGE |
Diagnostics |
50,000 |
CI23-10376 |
Preliminar demonstration and valorization of therapeutic rewiring of (partially) severed spinal cord |
Maurizio Prato |
Asociación Centro de Investigación Cooperativa en Biomateriales |
Individual |
N/A |
STAGE |
Medical Devices |
50,000 |
CI23-10380 |
New subset of neutrophils as a biomarker and a therapeutic target for metastatic breast cancer |
Maria de Guadalupe Gonçalves |
Universidade Nova de Lisboa |
Individual |
N/A |
STAGE |
Therapeutics |
49,000(*) |
CI23-10420 |
Isabelle Vernos |
Centre de Regulació Genòmica (CRG) |
Individual |
N/A |
STAGE |
Therapeutics |
50,000 |
|
CI23-10434 |
RACE Plus: AI-driven application to allow pre-hospital diagnosis and management of stroke patients |
Natalia Pérez de la Ossa |
Fundació Institut d’Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP) |
Individual |
N/A |
STAGE |
Digital Health |
50,000 |
CI23-10562 |
Developing a new therapeutic approach to overcome resistance to checkpoint inhibitors |
Rodrigo Toledo |
Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO) |
Individual |
N/A |
STAGE |
Therapeutics |
48,700 |
CI23-20154 |
New Biomarker for NAFLD and NASH Development and Progression |
David Martinez |
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR) |
Individual |
N/A |
STAGE |
Diagnostics |
50,000 |
CI23-20369 |
CarboSign7 for pancreatic cancer diagnosis: Biosampling optimization |
Oscar Pozo |
Fundació Institut Hospital del Mar d'Investigacions Mèdiques (IMIM) |
Consortium |
Hospital del Mar - Parc de Salut MAR |
STAGE |
Diagnostics |
50,000 |
CI23-20043 |
Novel gut-restricted first-in-class therapy for Inflammatory Bowel Disease |
Isabel Huber |
Fundació Institut d'Investigació Sanitària Pere Virgili |
Individual |
|
STAGE |
Therapeutics |
150,000 |
CI23-20067 |
Novel far-red/NIR-activatable PDT agents for combating hypoxic tumors |
Vicente Marchán |
Universitat de Barcelona |
Individual |
N/A |
STAGE |
Therapeutics |
150,000 |
CI23-20148 |
Arteriovenous Fistula for Dialysis: Machine Learning based models for failure and Cardiac events |
José Ibeas |
Fundació Institut d'Investigació i Innovació Parc Taulí (I3PT) |
Individual |
N/A |
STAGE |
Digital Health |
150,000 |
CI23-20210 |
BlaDimiR, non-invasive urine-based diagnostic and therapy response predictor for bladder cancer |
Marta Dueñas |
Fundación para la Investigación Biomédica del Hospital Universitario 12 de Octubre |
Individual |
N/A |
STAGE |
Diagnostics |
143,000 |
CI23-20216 |
Judith Guasch |
Consejo Superior de Investigaciones Científicas (CSIC) |
Individual |
N/A |
STAGE |
Medical Devices |
150,000 |
|
CI23-20229 |
Humanized Wnt-11 antibodies for cancer therapy: further validation and asset development |
Robert Kypta |
Asociación Centro de Investigación Cooperativa en Biociencias-CIC bioGUNE |
Individual |
N/A |
STAGE |
Therapeutics |
150,000 |
CI23-20433 |
Microbiome-associated biomarkers for improved anal cancer prevention |
Sergio Serrano-Villar |
Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal |
Consortium |
Instituto de Catálisis y Petroleoquímica (ICP), CSIC Marie Curie, 2 – 28049 Madrid, Spain |
STAGE |
Diagnostics |
135,261 |
CI23-20487 |
Proof of concept for development of an ATMP based on modified pericytes for glioblastoma treatment |
Rut Valdor |
Universidad de Murcia |
Individual |
|
STAGE |
Therapeutics |
150,000 |
CI23-20514 |
Duacept, a novel bi-specific fusion protein to prevent transplant rejection |
Oriol Bestard |
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR) |
Individual |
N/A |
STAGE |
Therapeutics |
148,500 |
CI23-20559 |
Pilar Coy |
Universidad de Murcia |
Individual |
N/A |
STAGE |
Medical Devices |
149,500 |
|
CI23-30155 |
Maria Luz Martinez |
Asociación Centro de Investigación Cooperativa en Biociencias-CIC bioGUNE |
Individual |
N/A |
STAGE |
Therapeutics |
150,000 |
|
CI23-30260 |
MICROSCREEN_CRC: Microbial biomarker test for early diagnosis of colorectal cancer (MiCRC) |
Olfat Khannous |
Fundació Institut de Recerca Biomèdica (IRB Barcelona) |
Individual |
N/A |
STAGE |
Diagnostics |
150,000 |
CI23-30015 |
FIBROKIT: First IVD-based non-invasive monitoring of kidney fibrosis |
Francesc E. Borras |
Fundació Institut d’Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP) |
Individual |
N/A |
STAGE |
Diagnostics |
300,000 |
CI23-30316 |
LCOR mRNA NanoTherapies - A paradigm shift in immunotherapies against cancer |
Toni Celià-Terrassa |
Fundació Institut Hospital del Mar d'Investigacions Mèdiques (IMIM) |
Individual |
N/A |
STAGE |
Therapeutics |
500,000 |
(*) Project cofunded by the Fundação para a Ciência e a Tecnologia (FCT)